In recent trading session, Definitive Healthcare Corp (NASDAQ:DH) saw 0.47 million shares changing hands at last check today with its beta currently measuring 1.54. Company’s recent per share price level of $2.70 trading at $0.11 or 4.34% at last check today assigns it a market valuation of $411.52M. That most recent trading price of DH’s stock is at a discount of -209.26% from its 52-week high price of $8.35 and is indicating a premium of 5.56% from its 52-week low price of $2.55. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.8 million shares which gives us an average trading volume of 889.13K if we extend that period to 3-months.

For Definitive Healthcare Corp (DH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.71. Splitting up the data highlights that, out of 10 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 4 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.02 in the current quarter.

Definitive Healthcare Corp (NASDAQ:DH) trade information

Upright in the green today for gaining 4.34%, in the last five days DH remained trading in the red while hitting it’s week-highest on Monday, 03/10/25 when the stock touched $2.70 price level, adding 11.18% to its value on the day. Definitive Healthcare Corp’s shares saw a change of -34.25% in year-to-date performance and have moved -5.18% in past 5-day. Definitive Healthcare Corp (NASDAQ:DH) showed a performance of -48.43% in past 30-days. Number of shares sold short was 2.77 million shares which calculate 2.65 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 7 to the stock, which implies a rise of 61.43% to its recent value today. Analysts have been projecting 7 as a low price target for the stock while placing it at a high target of 7. It follows that stock’s current price would drop -159.26% in reaching the projected high whereas dropping to the targeted low would mean a loss of -159.26% for stock’s current value.

Definitive Healthcare Corp (DH) estimates and forecasts

This year revenue growth is estimated to fall -6.83% from the last financial year’s standing.

12 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 56.2M for the same. And 12 analysts are in estimates of company making revenue of 58.29M in the next quarter. Company posted 63.48M and 63.74M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -70.74% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -38.36% while estimates for its earnings growth in next 5 years are of -4.57%.

Definitive Healthcare Corp (NASDAQ:DH)’s Major holders

Insiders are in possession of 7.14% of company’s total shares while institution are holding 94.68 percent of that, with stock having share float percentage of 101.96%. Investors also watch the number of corporate investors in a company very closely, which is 94.68% institutions for Definitive Healthcare Corp that are currently holding shares of the company. ADVENT INTERNATIONAL CORP/MA is the top institutional holder at DH for having 62.49 million shares of worth $341.22 million. And as of 2024-06-30, it was holding 53.2162 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 4.66 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.9712 of outstanding shares, having a total worth of $25.46 million.

On the other hand, MFS New Discovery Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024, the former fund manager was holding 3.7 shares of worth $9.93 million or 3.27% of the total outstanding shares. The later fund manager was in possession of 1.47 shares on Dec 31, 2024, making its stake of worth around $3.96 million in the company or a holder of 1.31% of company’s stock.